查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589497

數位偏頭痛治療設備市場：按產品類型、應用分類 - 2025-2030 年全球預測

Digital Migraine Treatment Devices Market by Product Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位偏頭痛治療市值為3.8571億美元，預計到2024年將達到4.3192億美元，複合年成長率為12.07%，到2030年將達到8.5672億美元。

數位偏頭痛治療設備是一種創新的醫療保健解決方案，旨在利用神經調節和生物回饋療法等技術，透過非藥物干預來緩解偏頭痛症狀。這些設備是傳統藥物療法的非侵入性治療方法，透過電、磁或熱刺激改變大腦活動，旨在治療偏頭痛。由於偏頭痛的盛行率不斷上升以及對比傳統藥物副作用較少的治療方法的需求，對這些設備的需求正在增加。這些設備主要應用於疼痛管理和神經治療，對於慢性和陣發性偏頭痛患者至關重要。最終用戶包括醫療機構、採用遠端保健解決方案的個人消費者以及健康診所。

主要市場統計
基準年[2023] 38571萬美元
預測年份 [2024] 43192萬美元
預測年份 [2030] 85672萬美元
複合年成長率（%） 12.07%

市場成長的主要影響因素包括數位健康解決方案意識的提高、技術進步和個人化醫療的推廣。潛在的市場機會來自擴大採用具有方便用戶使用界面的攜帶式和穿戴式設備，並與行動醫療應用程式整合以進行即時追蹤和資料分析。關鍵的成長機會之一是擴大全球意識宣傳活動以及醫療保健提供者和高科技公司之間的夥伴關係，以提高產品的可及性和教育水平。然而，市場限制包括高昂的設備成本、監管挑戰、有限的保險範圍以及與傳統治療相比療效的懷疑。此外，技術故障和資料隱私問題也可能是一個挑戰。

創新機會在於人工智慧和機器學習的交叉點，旨在預測偏頭痛模式並客製化干涉措施。新的研究領域包括調查數位設備與藥物治療相結合的有效性以及提高設備的易用性和舒適度。為了實現業務成長，公司正在投資強大的臨床試驗來建立療效，尋求與健康科技公司的策略聯盟，並確保市場的滲透率良好，例如亞洲和拉丁美洲的部分地區。這個市場的本質是動態的，技術進步和消費者健康意識推動著綜合健康管理解決方案的發展。

市場動態：快速發展的數位偏頭痛治療設備市場的關鍵市場洞察

數位偏頭痛治療市場正在因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 偏頭痛患者增加
    • 對微創治療的需求
    • 增加醫療支出以提高服務能力
  • 市場限制因素
    • 處理設備高成本
  • 市場機會
    • 數位偏頭痛治療設備的技術進步
    • 穿戴式裝置的成長趨勢
  • 市場挑戰
    • 限制取得和取得先進設備

波特五力：駕馭數位偏頭痛治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解數位偏頭痛治療設備市場的外部影響

外部宏觀環境因素在塑造數位偏頭痛治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解數位偏頭痛治療設備市場的競爭狀況

對數位偏頭痛治療設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣數位偏頭痛治療設備市場供應商的績效評估

FPNV 定位矩陣是評估數位偏頭痛治療設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪數位偏頭痛治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對數位偏頭痛治療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 偏頭痛盛行率增加
      • 對微創治療方法的需求
      • 增加醫療費用以提高服務能力
    • 抑制因素
      • 處理設備高成本
    • 機會
      • 數位偏頭痛治療設備的技術進步
      • 穿戴式裝置的成長趨勢
    • 任務
      • 存取或使用高級設備受到限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章數位偏頭痛治療設備市場：依產品類型

  • 枕神經刺激數位偏頭痛治療儀
  • 單脈衝經顱磁刺激數位化偏頭痛治療儀
  • 眶上刺激數位化偏頭痛治療儀
  • 迷走神經刺激數位偏頭痛治療儀

第7章數位偏頭痛治療設備市場：依應用分類

  • 醫院
  • 專科診所

第8章北美和南美數位偏頭痛治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區數位偏頭痛治療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲數位偏頭痛治療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Allodynic Therapeutics, LLC
  • Amgen Inc.
  • Bayer AG
  • Cefaly Technology
  • Cirrus Healthcare Products
  • electroCore, Inc
  • Eli Lilly and Company
  • eNeura Inc.
  • GlaxoSmithKline plc.
  • Neurolief Ltd.
  • Neuros Medical, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Salvia BioElectronics BV
  • Theranica Bio-Electronics Ltd.
Product Code: MRR-FB6C9E792BE4

The Digital Migraine Treatment Devices Market was valued at USD 385.71 million in 2023, expected to reach USD 431.92 million in 2024, and is projected to grow at a CAGR of 12.07%, to USD 856.72 million by 2030.

Digital migraine treatment devices are innovative healthcare solutions designed to alleviate migraine symptoms through non-pharmacological interventions, utilizing technologies like neuromodulation and biofeedback. These devices offer a non-invasive alternative to traditional medication, targeting migraine treatment via electrical, magnetic, or thermal stimulation to modify brain activity. The necessity of these devices is growing, driven by the increasing prevalence of migraines and the demand for treatments with fewer side effects compared to conventional drugs. They're primarily applied in pain management and neurological therapies, crucial for both chronic and episodic migraine sufferers. End-users span across healthcare facilities, individual consumers adopting telehealth solutions, and wellness clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 385.71 million
Estimated Year [2024] USD 431.92 million
Forecast Year [2030] USD 856.72 million
CAGR (%) 12.07%

Key market growth influences include rising awareness of digital health solutions, advancements in technology, and the push for personalized medicine. Potential market opportunities stem from the increasing adoption of portable and wearable devices with user-friendly interfaces and integration with mobile health apps for real-time tracking and data analysis. One significant growth opportunity is expanding global awareness campaigns and partnerships between healthcare providers and tech companies to enhance product accessibility and education. However, market limitations include high device costs, regulatory challenges, limited insurance coverage, and skepticism regarding their efficacy compared to traditional treatments. Additionally, technological malfunctions and data privacy concerns can pose challenges.

Innovation opportunities lie at the intersection of AI and machine learning, aiming to predict migraine patterns and tailor interventions. Emerging research areas include exploring the efficacy of combining digital devices with pharmacotherapy and improving the comfort and ease of device use. For business growth, companies should invest in robust clinical trials to establish efficacy, seek strategic collaborations with health tech firms, and focus on regions with underpenetrated markets like parts of Asia and Latin America. The nature of this market is dynamic, with technology advancements and consumer health awareness driving its evolution towards integrated health management solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Migraine Treatment Devices Market

The Digital Migraine Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of migraine patients
    • Demand for less invasive therapeutics
    • Growing healthcare expenditure on improving their service capabilities
  • Market Restraints
    • High cost of treatment devices
  • Market Opportunities
    • Technology advancements in the digital migraine treatment devices
    • Increasing trend of wearable devices
  • Market Challenges
    • Limited access or availability to advanced devices

Porter's Five Forces: A Strategic Tool for Navigating the Digital Migraine Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Migraine Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Migraine Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Migraine Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Migraine Treatment Devices Market

A detailed market share analysis in the Digital Migraine Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Migraine Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Migraine Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Migraine Treatment Devices Market

A strategic analysis of the Digital Migraine Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Migraine Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Allodynic Therapeutics, LLC, Amgen Inc., Bayer AG, Cefaly Technology, Cirrus Healthcare Products, electroCore, Inc, Eli Lilly and Company, eNeura Inc., GlaxoSmithKline plc., Neurolief Ltd., Neuros Medical, Inc., Novartis AG, Pfizer Inc., Salvia BioElectronics B.V., and Theranica Bio-Electronics Ltd..

Market Segmentation & Coverage

This research report categorizes the Digital Migraine Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Occipital Nerve Stimulation Digital Migraine Treatment Devices, Single-pulse Transcranial Magnetic Stimulation Digital Migraine Treatment Devices, Supraorbital Stimulation Digital Migraine Treatment Devices, and Vagus Nerve Stimulation Digital Migraine Treatment Devices.
  • Based on Application, market is studied across Hospitals and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of migraine patients
      • 5.1.1.2. Demand for less invasive therapeutics
      • 5.1.1.3. Growing healthcare expenditure on improving their service capabilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology advancements in the digital migraine treatment devices
      • 5.1.3.2. Increasing trend of wearable devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited access or availability to advanced devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Migraine Treatment Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Occipital Nerve Stimulation Digital Migraine Treatment Devices
  • 6.3. Single-pulse Transcranial Magnetic Stimulation Digital Migraine Treatment Devices
  • 6.4. Supraorbital Stimulation Digital Migraine Treatment Devices
  • 6.5. Vagus Nerve Stimulation Digital Migraine Treatment Devices

7. Digital Migraine Treatment Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Clinics

8. Americas Digital Migraine Treatment Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Migraine Treatment Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Migraine Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allodynic Therapeutics, LLC
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. Cefaly Technology
  • 5. Cirrus Healthcare Products
  • 6. electroCore, Inc
  • 7. Eli Lilly and Company
  • 8. eNeura Inc.
  • 9. GlaxoSmithKline plc.
  • 10. Neurolief Ltd.
  • 11. Neuros Medical, Inc.
  • 12. Novartis AG
  • 13. Pfizer Inc.
  • 14. Salvia BioElectronics B.V.
  • 15. Theranica Bio-Electronics Ltd.

LIST OF FIGURES

  • FIGURE 1. DIGITAL MIGRAINE TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL MIGRAINE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL MIGRAINE TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY OCCIPITAL NERVE STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SINGLE-PULSE TRANSCRANIAL MAGNETIC STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SUPRAORBITAL STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION DIGITAL MIGRAINE TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM DIGITAL MIGRAINE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. DIGITAL MIGRAINE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. DIGITAL MIGRAINE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023